// App-Quantinova.ai

1537 : Variation in protein-coding sequence and the genetic basis of cisplatin-induced toxicities among testicular cancer survivors (TCS) in the Platinum Study.

Researchers

Presenter

  • Eric R Gamazon

Principal Investigators

  • Heather E. Wheeler

  • Robert D. Frisina

  • Omar El Charif

  • Taisei Mushiroda

  • Michiaki Kubo

  • Shirin Ardeshir-Rouhani-Fard

  • Darren R. Feldman

  • Robert James Hamilton

  • David J. Vaughn

  • Clair J. Beard

  • Chunkit Fung

  • Sophie D. Fossa

  • Lawrence H. Einhorn

  • Nancy Cox

  • M. Eileen Dolan

  • Lois B. Travis

Medical Centers

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Departments of Biology and Computer Science, Loyola University Chicago, Chicago, IL

  • University of South Florida, Tampa, FL

  • The University of Chicago Medical Center, Chicago, IL

  • Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

  • RIKEN Center for Integrative Medical Science, Yokohama, Japan

  • School of Public Health, Indiana University, Bloomington, IN

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • Harvard University, Boston, MA

  • Wilmot Cancer Center, Rochester, NY

  • Oslo University Hospital, University of Oslo, Oslo, Norway

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Vanderbilt University, Nashville, TN

  • The University of Chicago Medical Center, Chicago, IL

  • Department of Medical Oncology, Indiana University, Indianapolis, IN

Locations

  • Canada

  • Japan

  • Norway

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Testicular cancer

  • Solid malignancies

Biomarkers

  • Transcription factor Maf

Drug/Treatment

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final